TAT-cyclo-CLLFVY TFA Catalog No.:M17672-C Anti-egfr antibody drug conjugates

Anti-egfr antibody drug conjugates

with maximal inhibition of 58% to 75% at the dose of 30 mg/kg/day

binds to IAP ligand via a linker to form SNIPER

InChi: InChI=1S/C22H16ClN3O2/c23-16-7-5-15(6-8-16)13-26-14-19(18-3-1-2-4-20(18)26)21(27)22(28)25-17-9-11-24-12-10-17/h1-12

and PANK3 with IC50s of 48

TAT-cyclo-CLLFVY TFA Catalog No.:M17672-C Anti-egfr antibody drug conjugatesTAT cyclo CLLFVY TFA is a cyclic peptide inhibitor of HIF 1 heterodimerization that inhibits hypoxia signaling in cancer cells. TAT cyclo CLLFVY TFA disrupts HIF 1 HIF 1 protein protein interaction with an IC50 of 1. 3 M. Product information Molecular Weight: 2673. 10 Formula: C113H189F3N42O26S2 Chemical Name: (2S) 5 amino 2 [[(2S) 1 [(2S) 1 [(2S) 2 [[(2S) 2 [[(2S) 2 [[(2S) 5 amino 2 [[(2S) 2 [[(2S) 2 [[(2S) 6 amino 2 [[(2S) 6 amino 2 [[(2S) 2 [[2